Peruvoside: Difference between revisions

Peruvoside
Clinical data
ATC code	C01AX02 (WHO) ;
Identifiers
	IUPAC name (3S,5R,10R,13R,14S,17R)-3-[(2S,5R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy -13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17 -tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde;
CAS Number	1182-87-2;
PubChem CID	14449;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C30H44O9
Molar mass	548.665 g/mol

Revision as of 15:58, 23 July 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Peruvoside (or cannogenin thevetoside) is a cardiac glycoside^[1] for heart failure.^[2]

It is derived from Cascabela thevetia (Thevetia neriifolia).^[2]

↑ Arora, R. B.; Rangaswami, S. (1972). Peruvoside and Other Cardiotonic Glycoside[s] of Thevetia neriifolia Juss: Chemical, Pharmacological, and Clinical Studies. New Delhi, India: Thomson. LCCN 78900408.
↑ ^2.0 ^2.1 Bhatia, M. L.; Manchanda, S. C.; Roy, S. B. (1970). "Haemodynamic Studies with Peruvoside in Human Congestive Heart Failure". British Medical Journal. 3 (5725): 740–743. doi:10.1136/bmj.3.5725.740. PMC 1701679. PMID 4919553.

@@ Line 29: / Line 29: @@
 {{CMG}}
+==Overview==
+'''Peruvoside''' (or '''cannogenin thevetoside''') is a [[cardiac glycoside]]<ref>{{ cite book | title = Peruvoside and Other Cardiotonic Glycoside[s] of Thevetia neriifolia Juss: Chemical, Pharmacological, and Clinical Studies | author = Arora, R. B.; Rangaswami, S. | year = 1972 | publisher = Thomson | location = New Delhi, India | lccn = 78900408}}</ref> for [[heart failure]].<ref name="pmid4919553">{{cite journal | author = Bhatia, M. L.; Manchanda, S. C.; Roy, S. B. | title = Haemodynamic Studies with Peruvoside in Human Congestive Heart Failure | journal = British Medical Journal | year = 1970 | volume = 3 | issue = 5725 | pages = 740–743 | pmid = 4919553 | pmc = 1701679 | doi = 10.1136/bmj.3.5725.740 }}</ref>
+It is derived from ''Cascabela thevetia'' (''Thevetia neriifolia'').<ref name="pmid4919553" />
-==Overview==
-'''Peruvoside''' (or '''cannogenin thevetoside''') is a [[cardiac glycoside]].<ref>''Peruvoside and Other Cardiotonic Glycoside[s] of Thevetia nereifolia; Chemical, Pharmacological, and Clinical Studies.''  Arora, R. B.; Rangaswami, S. (1972), Publisher: (Thomson,  New Delhi, India)</ref>
 ==References==
 {{reflist|2}}
 {{Cardiac glycosides}}
 [[Category:Cardiac glycosides]]
+[[Categpry:Cardiovascular Drugs]]
 [[Category:Drugs]]
 {{WikiDoc Help Menu}}
 {{WikiDoc Sources}}

Clinical data

ATC code	C01AX02 (WHO)
Identifiers
IUPAC name (3S,5R,10R,13R,14S,17R)-3-[(2S,5R)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy -13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17 -tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde
CAS Number	1182-87-2
PubChem CID	14449
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₃₀H₄₄O₉
Molar mass	548.665 g/mol